As for children with HoFH, the FDA only approved Repatha for use in combination with other LDL-lowering medications. Some examples of other LDL-lowering therapies may include statins and ezetimibe.

Repatha (evolocumab) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved use of Repatha to: For some uses, Repatha is prescribed in combination with a ...

Factors that may affect the price you’ll pay for Repatha include: your treatment plan your insurance coverage the pharmacy you use any equipment you may need to purchase, such as needles and ...

In the UK meanwhile, even with the discounted price on offer for Repatha, there have been suggestions that the drug may see its use restricted, with the National Institute for Health and Care ...

Sales of Repatha grew slowly since launch to reach ... New cardiovascular outcomes data has helped the two drugs build a case for broader use, but they are also facing a challenge from a new ...

He emphasized a robust portfolio, including 14 medicines now annualizing over $1 billion each, and significant momentum in novel medicines like Repatha and EVENITY. Repatha sales grew 36% year ...

Repatha generated revenues of $606 million, up 45% year over year, driven by higher volume growth. Repatha volume growth was driven by broad reimbursement and removal of prior authorization ...

Rising incidences of CVDs have been linked to poor diet, lack of physical activity, tobacco use, excessive alcohol consumption, high blood pressure, and genetic predisposition. Repatha evolocumab ...